Back to all studies
Active Not RecruitingNCT05905003

Accelerating Medicines Partnership® Schizophrenia Observational Study: Psychosis Risk Evaluation, Data Integration, and Computational Technologies -Data Processing, Analysis, and Coordination Center and Coordination Center

This study is active but not recruiting in the United States, in Australia, in Canada, .... It focuses on schizophrenia.

Schizophrenia, Clinical High Risk, ...ObservationalFrom 12 Years to 30 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This observational study follows people living with schizophrenia to understand their experience, outcomes, or changes over time.

What would participation involve?

Participants may answer questionnaires, join interviews, or provide follow-up information, attend study visits with the research team. The registry lists locations in Australia, in Canada, and in Chile.

Who is it mainly for?

This study appears to be mainly for people with schizophrenia.

What should you check before joining?

Ask about whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: June 2, 2022
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
2,617
Sponsor
Brigham and Women's Hospital
Sponsor type
Hospital / academic medical center
Study type
Observational
Intervention type
Interview / survey / observational
Study phase
Not clearly listed
Locations
United States, Australia, Canada, ...
Age range
From 12 Years to 30 Years
Official registry ID
NCT05905003
Official title
Accelerating Medicines Partnership® Schizophrenia Observational Study: Psychosis Risk Evaluation, Data Integration, and Computational Technologies -Data Processing, Analysis, and Coordination Center and Coordination Center

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT05905003. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Australia · 7 sites
  • HEP and co-located Headspace Adelaide
    Adelaide, South Australia
    Site status: Not listed — confirm with the team
  • Headspace, Craigieburn
    Craigieburn, Victoria
    Site status: Not listed — confirm with the team
  • Headspace, Glenroy
    Glenroy, Victoria
    Site status: Not listed — confirm with the team
  • Headspace Melton
    Melton South, Victoria
    Site status: Not listed — confirm with the team
  • Orygen Specialist Programs, Melbourne
    Parkville, Victoria
    Site status: Not listed — confirm with the team
  • Headspace, Sunshine
    Sunshine, Victoria
    Site status: Not listed — confirm with the team
  • Headspace, Werribee
    Werribee, Victoria
    Site status: Not listed — confirm with the team
Canada · 2 sites
  • University of Calgary
    Calgary, Alberta
    Site status: Not listed — confirm with the team
  • McGill University
    Montreal, Quebec
    Site status: Not listed — confirm with the team
Chile · 1 site
  • Hospital Clínico Universidad de Chile (HCUCH)
    Santiago, Santiago Metropolitan
    Site status: Not listed — confirm with the team
China · 1 site
  • Shanghai Jiao Tong University
    Shanghai
    Site status: Not listed — confirm with the team
Denmark · 1 site
  • Copenhagen Research Center for Mental Health (CORE)
    Copenhagen
    Site status: Not listed — confirm with the team
Germany · 3 sites
  • Klinik für Psychiatrie und Psychotherapie, University of Cologne
    Cologne, Brescia
    Site status: Not listed — confirm with the team
  • The University Hospital Jena, Department of Psychiatry
    Jena, Thuringia
    Site status: Not listed — confirm with the team
  • Ludwig-Maximilians-Universität Munich
    Munich
    Site status: Not listed — confirm with the team
Hong Kong · 1 site
  • The University of Hong Kong, Department of Psychiatry
    Hong Kong
    Site status: Not listed — confirm with the team
Italy · 1 site
  • University of Pavia
    Pavia, Pavia
    Site status: Not listed — confirm with the team
Singapore · 1 site
  • Early Psychosis Intervention Programme (EPIP) Clinic, Institute of Mental Health
    Singapore
    Site status: Not listed — confirm with the team
South Korea · 2 sites
  • Department of Psychiatry, Chonnam National University Hospital & Mindlink
    Gwangju
    Site status: Not listed — confirm with the team
  • Seoul National University College of Medicine
    Seoul
    Site status: Not listed — confirm with the team
Spain · 1 site
  • Instituto de Psiquiatría y Salud Mental Hospital General Universitario Gregorio Marañón
    Madrid
    Site status: Not listed — confirm with the team
Switzerland · 1 site
  • Treatment and Early Intervention in Psychosis Program (TIPP) & Center for Psychiatric Neuroscience (CNP), Department of Psychiatry, Lausanne University Hospital
    Lausanne
    Site status: Not listed — confirm with the team
United Kingdom · 3 sites
  • Forward Thinking Birmingham
    Birmingham
    Site status: Not listed — confirm with the team
  • University of Cambridge
    Cambridge
    Site status: Not listed — confirm with the team
  • King's College London
    London
    Site status: Not listed — confirm with the team
United States · 17 sites
  • University of California Irvine
    Irvine, California
    Site status: Not listed — confirm with the team
  • University of California Los Angeles
    Los Angeles, California
    Site status: Not listed — confirm with the team
  • University of California San Diego
    San Diego, California
    Site status: Not listed — confirm with the team
  • University of California San Francisco
    San Francisco, California
    Site status: Not listed — confirm with the team
  • Hartford Healthcare
    Hartford, Connecticut
    Site status: Not listed — confirm with the team
  • Yale University/Connecticut Mental Health Center
    New Haven, Connecticut
    Site status: Not listed — confirm with the team
  • University of Georgia
    Athens, Georgia
    Site status: Not listed — confirm with the team
  • Northwestern University
    Evanston, Illinois
    Site status: Not listed — confirm with the team
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts
    Site status: Not listed — confirm with the team
  • Washington University
    St Louis, Missouri
    Site status: Not listed — confirm with the team
  • Icahn School of Medicine at Mount Sinai
    New York, New York
    Site status: Not listed — confirm with the team
  • Northwell Health
    Queens, New York
    Site status: Not listed — confirm with the team
  • University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina
    Site status: Not listed — confirm with the team
  • University of Oregon
    Eugene, Oregon
    Site status: Not listed — confirm with the team
  • University of Pennsylvania
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Temple University
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • University of Pittsburgh
    Pittsburgh, Pennsylvania
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring observational follow-up for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Is this an interview, survey, or observational study?

This appears to be a interview / survey / observational study. Phase is mainly useful to check for medication studies and some device studies.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 12 Years to 30 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to answer questionnaires or take part in interviews. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

Could the questions feel emotionally difficult or personal?

If the study involves interviews or questionnaires, some questions may feel personal or emotionally sensitive. Ask whether you can skip questions, pause, stop, and how your answers will be protected. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Brigham and Women's Hospital, which appears to be a hospital or academic medical center. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me